HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.

Abstract
The major shortcoming of present day treatment of leukemia by bone marrow transplantation (BMT) remains leukemia relapse. It has become clear that a graft-versus-host reaction (GVHR) is accompanied by a graft-versus-leukemia reaction (GVLR) which may prevent leukemia relapse. In two non-immunogenic rat leukemia models, the Brown Norway acute myelocytic leukemia (BNML) and the WAG/Rij acute lymphocytic leukemia L4415, total body irradiation (TBI) was given to induce 'minimal residual disease' (MRD). Subsequently, it was attempted to evoke a GVLR by using syngeneic or allogeneic BMT, with or without addition of graded numbers of lymphocytes. In both leukemia models the addition of high numbers of syngeneic lymphocytes to the syngeneic graft had no antileukemic effect. Allogeneic marrow grafts, which contain at the most 8% lymphocytes, only resulted in a GVLR when splenocytes were added. The therapeutic window was found to be narrow, i.e. in fully mismatched BMT the number of allogeneic splenocytes resulting in a significant GVLR (2-3 log leukemic cell kill) without inducing (lethal) acute GVHD was critical. Increasing the number of allogeneic spleen cells added to the allogeneic BM graft induced lethal acute GVHD. To date, our data indicate that the GVLR is an allogeneic effect, inseparable from GVHD.
AuthorsT C Kloosterman, M J Tielemans, A C Martens, D W van Bekkum, A Hagenbeek
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 14 Issue 1 Pg. 15-22 (Jul 1994) ISSN: 0268-3369 [Print] England
PMID7951103 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Animals
  • Bone Marrow Transplantation (immunology)
  • Disease Models, Animal
  • Female
  • Graft vs Host Reaction (immunology)
  • Humans
  • Leukemia, Experimental (immunology, pathology, therapy)
  • Leukemia, Myeloid, Acute (immunology, pathology, therapy)
  • Liver (pathology)
  • Male
  • Organ Size
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (immunology, pathology, therapy)
  • Rats
  • Rats, Inbred BN
  • Rats, Inbred Strains
  • Rats, Wistar
  • Spleen (pathology)
  • T-Lymphocytes (immunology)
  • Transplantation, Homologous
  • Transplantation, Isogeneic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: